Uterine ®broid embolization (UFE) is a new minimally-invasive treatment option for leiomyomata of the uterus leading to symptomatic improvement and shrinkage of the ®broids. We present a case of restoration of the uterine architecture after disintegration and stepwise expulsion of infarcted leiomyoma tissue 7 months after UFE for leiomyoma-related menorrhagia.
Introduction
Uterine ®broid embolization (UFE) of symptomatic uterine leiomyomata was ®rst reported by Ravina et al. in 1995 (Ravina et al., 1995 . Studies performed since then have shown the short-and midterm effectiveness of UFE in relieving bleeding and bulk symptoms associated with ®broid disease (Ravina et al., 1997; Hutchins and WorthingtonKirsch, 2000; Pelage et al., 2000; McLucas et al., 2001a; Spies et al., 2001; Katsumori et al., 2002) . UFE leads to infarction with subsequent shrinkage of targeted ®broids while preserving the perfusion of the normal myometrium (deSouza and Williams, 2002) . The general policy so far has been not to offer UFE to patients who particularly want to conceive because perfusion and architectural integrity of the uterus might be compromised after UFE. We present a patient in whom follow-up magnetic resonance imaging (MRI) 7 months after UFE showed restoration of the uterus following sloughing and stepwise expulsion by the vaginal route of an 8 cm intramural ®broid.
Case report
A 48-year-old primigravid patient with known ®broid disease for several years but an otherwise uneventful gynaecological history presented to our hospital with menorrhagia, urinary frequency during day-time hours, and a feeling of tightness and pressure in the pelvic area. Menstrual bleeding had worsened over the preceding 8 months and remained unchanged despite medical therapy. One month prior to admission the patient had a dilatation and curettage with resection of an endometrial polyp in another hospital. Hysterectomy was offered for treatment of menorrhagia. The patient refused surgery and opted for uterine ®broid embolization instead and was referred to our hospital. MRI on admission showed an 83 mm Q 71 mm Q 84 mm intramural leiomyoma distorting the uterine cavity (Figure 1a ,b) and a 23 mm Q 23 mm Q 28 mm subserosal leiomyoma (not shown). Under local anaesthesia angiographyguided access to the uterine artery was established and transarterial catheter-directed bilateral embolization of the ®broids was performed using 700±900 mm tris-acryl gelatin microspheres (Embosphere; Biosphere Medical, Paris, France). The procedure itself was uneventful. Contrast-enhanced MRI obtained 48 h after UFE showed complete infarction of the large ®broid ( Figure 2 ) while perfusion of the surrounding myometrium was preserved.
The patient returned for follow-up 7 months after UFE and reported complete resolution of her symptoms. Menses were described as light and regular while tightness and pressure in the pelvic area had completely resolved. In addition she reported a vaginal discharge for about 4 months with expulsion of tissue fragments. Discharge and tissue passage were considered a minor problem by the patient and antibiotics were given by her gynaecologist although an infective agent could not be isolated. The discharge had stopped 4 weeks prior to 7 month follow-up at our institution. MRI performed on follow-up showed a regular uterine architecture and a ®broid remnant of 10 mm at the site of the large leiomyoma seen before treatment (Figure 3a,b) . The second intramural ®broid had shrunk to a size of 12 mm Q 11 mm Q 8 mm (not shown). 
Discussion
Partial or complete expulsion of leiomyomata has been reported in the literature after successful uterine ®broid embolization (Abbara et al., 1999; Berkowitz et al., 1999) . It has also been observed after laparoscopic bipolar coagulation of uterine arteries and as a result of GnRH agonist therapy (Liu et al., 2001; Yu et al., 2001) . Since uterine ®broid embolization is being used increasingly as the primary treatment option in patients with symptomatic uterine ®broids one has to be aware of the possibility of ®broid expulsion occurring weeks to months after the intervention. Patients may present with different symptoms ranging from cramping pain with or without evidence of infection and continuous bleeding to minor symptoms like vaginal discharge and passage of tissue fragments, as in our case. Appropriate management includes expectant management with administration of drugs for pain relief and antibiotics if there is evidence of infection. Hysteroscopic evaluation and resection/evacuation of infarcted ®broid tissue may be necessary in patients who do not respond to supportive treatment and in patients who are not able to pass the ®broid tissue on their own. Furthermore, if patients present with prolonged discharge after UFE that does not respond to antibiotics, dilatation and curettage or hysteroscopy should be considered rather than continued use of antibiotics. MRI with its excellent soft tissue contrast and unrestricted ability to evaluate the uterine architecture as well as perfusion of the uterus and ®broids is a very useful tool in directing treatment in equivocal cases and ruling out treatment failure due to ®broid re-growth. Full-term pregnancies have been reported after successful UFE but given the current lack of data on fertility rate and outcome of pregnancies UFE should be reserved for women who do not desire future fertility unless there is no alternative to hysterectomy or myomectomy McLucas et al., 2001) .
Theoretically UFE may lead to perfusion changes with atrophy of the endometrium and malnourishment of the implant due to insuf®ciency of the placenta. However, studies using contrast-enhanced MRI after UFE showed normal myometrial and endometrial perfusion 1 month after UFE and restriction of infarction to the ®broids treated (deSouza and Williams, 2002) . Shrinkage of ®broids after UFE may be impressive and reduce distortion of the uterine cavity thus enabling implantation of the embryo. Nevertheless, infarcted ®broids may represent a weak point in the uterine wall and increase the risk of uterine rupture during pregnancy, although this possible risk has not been mentioned in the literature to date. Partial disruption of the uterine wall with ®broid remnants within a localized defect presumably representing ulceration after partial ®broid expulsion was reported after UFE by De Iaco and colleagues (De Iaco et al., 2002) . While such a ®nding may warrant treatment if the patient presents with new onset of menorrhagia, our case demonstrates that expulsion of even a ®broid as large as 8 cm can occur without any complications or the necessity to intervene. Moreover, expulsion or disintegration of ®broids following UFE may lead to a nearly complete architectural restoration of the uterine cavity as reported by Felemban et al. 2001 and illustrated by our case. Although this may occur in the minority of cases only, and especially in patients with intramural and submucous ®broids, this observation has potential implications for the possibility of future pregnancies in patients who undergo UFE for symptomatic ®broid disease.
